Prostaglandin synthesis inhibitors potentiate the BCG-induced augmentation of natural killer cell activity.
D000818:Animals; D001202:Ascitic Fluid / Q000166:cytology; D003602:Cytotoxicity, Immunologic; D007213:Indomethacin / Q000494:pharmacology; D007519:Isoantigens; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D009163:Mycobacterium bovis / Q000276:immunology*; D010586:Phagocytes / Q000276:immunology; D011453:Prostaglandins / Q000096:biosynthesis*; D011458:Prostaglandins E / Q000096:biosynthesis; D011460:Prostaglandins F / Q000096:biosynthesis; D013997:Time Factors
D007519:Isoantigens; D011453:Prostaglandins; D011458:Prostaglandins E; D011460:Prostaglandins F; D007213:Indomethacin